Study on Improving COVID-19 Vaccination in Rheumatologic Disease
This study is looking at different ways to encourage people with autoimmune and inflammatory rheumatic diseases (AIRD) to get the updated COVID-19 vaccine. It's testing several approaches: videos with patient stories about COVID-19 vaccination, videos and brochures on good oral health, and phone calls from patient navigators to offer support and information about the vaccine. The study aims to see if these methods help more people get vaccinated. You might be able to join if you are an adult (18+) with AIRD, are Black and/or Latinx, and haven't received the updated COVID-19 vaccine. The study will measure how many participants get vaccinated after 3 months. The current status of the study is unclear, and it plans to enroll 1170 people.
- Study design
- This is an interventional study, meaning participants will receive specific interventions. It plans to enroll 1170 participants.
- What's involved
- Participants will watch videos, receive brochures, and some will receive phone calls from patient navigators. The study measures vaccination status at 3 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 3 months to measure receipt of updated COVID-19 vaccination.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Testimonials and Navigation in Rheumatology
At a glance
Conditions
Where it's being run
3 sites across 2 statesStudy leadership
- Maria I Danila, MD, MSc, MSPH · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Receipt of updated COVID-19 vaccination.3 months
We will measure rates of receipt of updated COVID-19 vaccination.